Evidence map›Paper›PMID 34933920›Full record

ArticleLife science alliance2022

Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity.

Irene Riera-Tur, Tillman Schäfer, Daniel Hornburg, Archana Mishra, Miguel da Silva Padilha, Lorena Fernández-Mosquera, Dennis Feigenbutz, Patrick Auer, Matthias Mann, Wolfgang Baumeister and 5 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Lysosomal swelling triggers LRRK2 activity.bioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Therapeutic effects of a novel synthetic α-secretase.Frontiers in aging neuroscience · 2024
    Article
  8. Handling Difficult Cryo-ET Samples: A Study with Primary Neurons from Drosophila melanogaster.Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada · 2023
    Article
  9. Mechanisms and pathology of protein misfolding and aggregation.Nature reviews. Molecular cell biology · 2023
    Review
  10. Frontiers in aging neuroscience · 2023
    Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Irene Riera-TurDepartment of Molecules-Signaling-Development, Max Planck Institute of Neurobiology, Martinsried, Germany.
Tillman SchäferDepartment of Molecular Structural Biology, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID 0000-0002-9992-2501
Daniel HornburgDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID 0000-0002-6618-7774
Archana MishraDepartment of Molecules-Signaling-Development, Max Planck Institute of Neurobiology, Martinsried, Germany.
Miguel da Silva PadilhaDepartment of Molecules-Signaling-Development, Max Planck Institute of Neurobiology, Martinsried, Germany.
Lorena Fernández-MosqueraThe William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Dennis FeigenbutzDepartment of Molecules-Signaling-Development, Max Planck Institute of Neurobiology, Martinsried, Germany.
Patrick AuerDepartment of Molecules-Signaling-Development, Max Planck Institute of Neurobiology, Martinsried, Germany.
Matthias MannDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID 0000-0003-1292-4799
Wolfgang BaumeisterDepartment of Molecular Structural Biology, Max Planck Institute of Biochemistry, Martinsried, Germany.
Rüdiger KleinDepartment of Molecules-Signaling-Development, Max Planck Institute of Neurobiology, Martinsried, Germany.ORCID 0000-0003-1000-7989
Felix MeissnerExperimental Systems Immunology Group, Max Planck Institute of Biochemistry, Martinsried, Germany.
Nuno RaimundoDepartment of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, USA.ORCID 0000-0002-5988-9129
Rubén Fernández-BusnadiegoDepartment of Molecular Structural Biology, Max Planck Institute of Biochemistry, Martinsried, Germany ruben.fernandezbusnadiego@med.uni-goettingen.de.ORCID 0000-0002-8366-7622
Irina DudanovaDepartment of Molecules-Signaling-Development, Max Planck Institute of Neurobiology, Martinsried, Germany idudanova@neuro.mpg.de.ORCID 0000-0003-1052-8485
Max Planck Institute of Neurobiology · DEMax Planck Institute of Biochemistry · DEPenn State Milton S. Hershey Medical Center · USQueen Mary University of London · GBUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The autophagy-lysosomal pathway is impaired in many neurodegenerative diseases characterized by protein aggregation, but the link between aggregation and lysosomal dysfunction remains poorly understood. Here, we combine cryo-electron tomography, proteomics, and cell biology studies to investigate the effects of protein aggregates in primary neurons. We use artificial amyloid-like β-sheet proteins (β proteins) to focus on the gain-of-function aspect of aggregation. These proteins form fibrillar aggregates and cause neurotoxicity. We show that late stages of autophagy are impaired by the aggregates, resulting in lysosomal alterations reminiscent of lysosomal storage disorders. Mechanistically, β proteins interact with and sequester AP-3 μ1, a subunit of the AP-3 adaptor complex involved in protein trafficking to lysosomal organelles. This leads to destabilization of the AP-3 complex, missorting of AP-3 cargo, and lysosomal defects. Restoring AP-3μ1 expression ameliorates neurotoxicity caused by β proteins. Altogether, our results highlight the link between protein aggregation, lysosomal impairments, and neurotoxicity.

Indexed as

Gain of Function MutationAmyloid beta-PeptidesAmyloidogenic ProteinsCell SurvivalGene ExpressionLysosomesNeurodegenerative DiseasesNeuronsProtein AggregatesProtein Aggregation, PathologicalSignal TransductionAmyloid beta-PeptidesAmyloidogenic ProteinsProtein Aggregates

Identifiers

PMID34933920
PMCPMC8711852
OpenAlexW4200369642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.